Senior Global Market Development Manager SCIEX Marlborough, Massachusetts
Description: This presentation highlights the transformative impact of flexible analytical tools in early-stage drug discovery. Accurate mass ZenoTOF 8600 and 7600 SCIEX MS systems support both small and large molecule workflows with dual fragmentation (CID and EAD), enabling robust metabolite ID, structural characterization and quantification. Key applications, including intact mass analysis, peptide mapping, and MRMHR quantitation, allow confident detection and measurement of critical quality attributes (CQAs), streamlining bioanalytical workflows for complex and emerging therapeutic modalities.
Learning Objectives:
Understand the role of flexible MS technologies in large molecule bioanalysis.
Learn how dual-fragmentation techniques (CID and EAD) enhance structural elucidation and metabolite identification.
Gain insight into key workflows such as intact mass analysis, peptide mapping, and MRMHR for assessing critical quality attributes and biotransformations in protein and peptide drug products.
